Cogent Biosciences (COGT) Other financing activities (2018 - 2026)
Cogent Biosciences (COGT) posted quarterly Other financing activities of $1.1 million for Q1 2026, up 680.88% year-over-year from $136000.0 in Q1 2025, and up 100.5% quarter-over-quarter from -$214.4 million in Q4 2025.
Cogent Biosciences (COGT) Other financing activities (2018 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has reported Other financing activities for 8 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities rose 680.88% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $2.3 million (up 579.4% YoY), while the FY2025 annual figure was $1.3 million, up 578.39% from the prior year.
- Other financing activities grew to $1.1 million in Q1 2026 per COGT's latest filing, from -$214.4 million in the prior quarter.
- Across five years, Other financing activities topped out at $215.2 million in Q3 2025 and bottomed at -$214.4 million in Q4 2025.
- Historically, Other financing activities has averaged $245437.5 across 5 years, with a median of $174500.0 in 2023.
- On a YoY basis, Other financing activities climbed as much as 117060.87% in 2025 and fell as far as 794329.63% in 2025.
- Cogent Biosciences' Other financing activities stood at -$572000.0 in 2022, then surged by 137.24% to $213000.0 in 2023, then tumbled by 87.32% to $27000.0 in 2024, then tumbled by 794329.63% to -$214.4 million in 2025, then soared by 100.5% to $1.1 million in 2026.
- Business Quant data shows COGT's Other financing activities at $1.1 million in Q1 2026, -$214.4 million in Q4 2025, and $215.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.96 Mn |
| Jun 30, 2026 | 2.96 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | -214.44 Mn |
| Dec 31, 2025 | -214.44 Mn |
| Sep 30, 2025 | 215.21 Mn |
| Sep 30, 2025 | 215.21 Mn |
| Jun 30, 2025 | 448,000.00 |
| Jun 30, 2025 | 448,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | -184,000.00 |
| Sep 30, 2024 | -184,000.00 |
| Jun 30, 2024 | 356,000.00 |
| Jun 30, 2024 | 356,000.00 |
| Dec 31, 2023 | 213,000.00 |
| Dec 31, 2023 | 213,000.00 |